InsidersTradesSigma
Follow the 동화약품 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 동화약품 has published 2 reports. Market capitalisation: €128.3bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 동화약품. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
동화약품 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the research, development, and production of medicines and pharmaceutical products.